Prostate cancer

News

Prostate drug approved for use in non-metastatic cases

The US Food and Drug Administration has approved the drug Xtandi (enzalutamide) to treat men with advanced non-metastatic prostate cancer.

News

J&J gets quick approval for new next-gen prostate cancer dru...

The FDA has approved Johnson & Johnson’s next generation prostate cancer drug, apalutamide in an early but tough to treat form of prostate cancer that has not spread.

News

J&J files next generation prostate cancer drug in Europe

After having filed its new prostate cancer drug apalutamide with the FDA in October, Johnson & Johnson have now submitted the drug to Europe’s EMA.

News

US court invalidates key patent on J&J's Zytiga

J&J to appeal decision.

News

EU regulators back J&J's Zytiga in early prostate cancer use

New use could give J&J drug edge over Pfizer's rival

News

Pfizer confirms $14bn Medivation merger

Drug giant confirms press reports.

Prostate drug approved for use in non-metastatic cases

J&J gets quick approval for new next-gen prostate cancer dru...

J&J files next generation prostate cancer drug in Europe

US court invalidates key patent on J&J's Zytiga

EU regulators back J&J's Zytiga in early prostate cancer use

Pfizer confirms $14bn Medivation merger

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Prostate cancer

Editor's Picks